Blue Horseshoe Stocks: Options Reviews

OPTIONS REVIEW
-
We formulated two options ideas for yesterday morning’s premarket report, and with the help of a gap-and-go session for the overall markets, we saw appreciable gains in each and every contract we had designated for observation.

SPDR S&P500 (ETF) SPY -The SPY is always our go-to when we have a gut feeling about market sentiments, and the number of times we’ve found success with trading its options is practically uncountable at this point. Yesterday’s idea was no exception.

Our targets, the SPY Weekly 292-293.50 Calls performed admirably, providing ourselves and our readers with the following profit chances:

$292 Calls – Range: .91-2.04 – Max Gain: 124%
$292.50 Calls – Range: .60-1.53 – Max Gain: 155%
$293 Calls – Range: .33-1.07 – Max Gain: 224%
$293.50 Calls – Range: .14-.61 – Max Gain: 336%

_____

PVH Corp. PVH

Following a large Form-4 buy on the part of the CEO, we were interested in a longer-term play on PVH, highlighting the PVH 09/20 $75-85 Calls and those were able to get some traction on our first day of observation.

With an expiration still two weeks away, we’ll have plenty of time to realize any further gains, but the first day performance is certainly worthy of mentioning.

$75 Calls – Range: 5.10-7.02 – Max Gain: 38%
$80 Calls – Range: 2.00-3.40 – Max Gain: 70%
$85 Calls – Range: .55-1.25 – Max Gain: 127%


Fresh Options Idea:
PANW Weekly $215-222.50 Calls 


Extended Watchlist:
DSLV, LAIX, CDTX, SINT, INMD, ELTK, PHUN, ZUMZ, CEI

Blue Horseshoe Stocks: Fresh New Options Ideas

Alibaba Group Holding Ltd. BABA – Review
-
On Friday morning, apart from recapping the amazing options idea we proffered in last week’s reports, we formulated one final fresh idea for the week. That was the BABA Weekly $165-162.50 Puts, and the performance there did not disappoint.

We sussed out multibag options gainers all week long, and this short on BABA was a solid way to cap it all off. The $165 Puts ran from a low of .78 and reached 2.26, for an intraday gain of 190% The $162.50′s also fared quite well, running from 1.84-4.36, which represents a 137% rip.
______

SPDR S&P500 (ETF) SPY – Fresh Idea

In light of present conditions we’re observing, we’ll be staying on the short side of things with our fresh idea for today. We’re going to radar the SPY Weekly $290-288 Puts.

____

Bonus Ideas:
Allakos, Inc. ALLK 08/16 $45-60 Calls 

Boeing, Inc. BA 09/06 $340-350 Calls


Extended Watchist: 
CEI, OESX, AYTU, FBIO, SAND, USLV

Blue Horseshoe Stocks: Big Options Gainers & More

SPDR S&P500 ETF (SPY) – Recap

Yesterday morning in our premarket report, we formulated a fresh options idea with the SPY 05/15 $281-282.50 Calls after seeing that market conditions appeared to be gearing up for another session-over-session reversal after Monday’s selloff.

Our hunch proved accurate, with a bullish session similar to Friday’s going on the books yesterday, and it provided for some nice chances in our highlighted contracts.

$281 Calls – Range: 2.13-4.35 – Max Gain: 104%
$281.50 Calls – Range: 1.87-3.85  – Max Gain: 106%
$282 Calls – Range: 1.55-3.39 – Max Gain: 119%
$282.50 Calls – Range: 1.30-3.03  – Max Gain: 133%


Amplitech Group, Inc. AMPG – News

We’re revisiting AMPG again for the third straight time this week, after the company’s quarterly report was released yesterday, containing highlights for Q1 2019, which included bolstered sales, profits, and cash on hand. 

Some of the key financial highlights were as follows:

-Sales were $678.3K, up from $428.5K a year earlier, an improvement of $249.8K, or 58.3%

-Gross profits were $324.1K, up from $254.9K a year earlier, an improvement of $69.2K, or 27.1% Gross margins in Q1 were 47.8%, down from 59.5% the prior year.

-Operating Income in Q1 increased to $82.6K, up from $44.2K a year earlier, an improvement of $38.4K, or 86.9%

-Earnings before interest, tax, depreciation and amortization (EBITDA) for Q1 increased to $119.7K from $52.1K the prior year, an increase of $67.6 thousand, or 129.8%  EBITDA margins for the current quarter were 17.6 percent vs 12.2 percent in 2018, an improvement of 44.3 percent.

-Cash on hand increased from $442.1K in Q1 of 2018 to $783.6K in 2019, helped by improved profits as well as a new term debt facility which was secured in the first quarter. (>>View Full PR)

Be sure to check out the recent acquisition news from AMPG as well, which figures to improve the company’s sales by a significant margin.


FRESH OPTIONS IDEA:
Macy’s, Inc. M Weekly $22-23.50 Calls


Extended Watchlist:
CLRB, XXII, CEI, TLGT, HIIQ, HTBX, PEIX

Blue Horseshoe Stocks: Earnings-Related Options Ideas

OPTIONS REVIEW

We closed out the short week on Thursday with a pair of last minute options ideas, and both of those provided our readers and ourselves with the opportunity to take significant intraday profits.

United Rentals Inc. URI Weekly $134-136 Calls
$134 Calls – Range:
1.65-4.20  – Max Gain: 155%
$135 Calls – Range: .91-3.50 – Max Gain: 285%
$136 Calls – Range:
.85-2.73  – Max Gain: 221%

Union Pacific Corp. UNP Weekly $172.50 & 175 Calls
$172.50 Calls – Range: 2.61-5.07  – Max Gain: 94%
$175 Calls – Range: .84-2.95 – Max Gain: 251%

______

EARNINGS RELATED OPTIONS IDEAS
Halliburton Co. HAL Weekly $31.50-32.50 Calls
Kimberly Clark Corp. KMB Weekly $125-128 Calls


Moleculin Biotech, Inc. MBRX – Recap

We highlighted this play at the end of last month, and shortly thereafter we would observe a low of .7772. Last week, MBRX reached a new high of 1.47, which translates to a gain of 89% in roughly three weeks’ time.

The move, which filled the entirety of the topside gap on the chart, was due to Thursday’s revelation that the company’s drug Annamycin had received the FDA’s Approval for fast-track designation. At 4:30PM on Wednesday, MBRX officials will conduct a call to discuss this and other developments on a live webcast, which will be available in the Investor Relations section at www.moleculin.com.


Extended Watchlist:
NBRV, TLGT, FCEL, UXIN, TENX, COMM, KEG, CEI,

Blue Horseshoe Stocks: YGYI Update & More

Youngevity International Inc. YGYI

We began tracking YGYI the Thursday before last, on the 4th, and subsequently witnessed a low of 6.00 before the stock began to ascend sharply.

On Friday, despite already having produced significant gain opportunities for us, the YGYI once again made an impressive move, streaking to a new high of 14.40. That works out to an overall move of 140% accompanied by some of the highest volume sessions in the history of the stock.  As YGYI streaks to seven year highs and into the blue sky, we’ll continue to keep tabs on its activity.


Canadian Cannabis Legalization Finally Arrives

We have been proponents of the Canadian cannabis sector for quite a long time, and we have finally reached the moment we’ve been waiting for- the nationwide legalization of recreational marijuana. Originally slated for July, the delays will now finally come to an end, which means the fun is just getting started. Wednesday is the big day.

Here is a list of Canadian cannabis stocks that we’ve tracked in the past to watch in the midst of this very exciting, key moment in Canada’s history, and indeed the history of cannabis itself:

ACBFF, APHQF, ATTBF, CRON, GLDFF, GLNNF, ISOLF, NXTTF, MRRCF, SPRWF, & TWMJF


Extended Watchlist: 
ARNC, LEVB, LLL, HRS, TKC, INO, EARS, CEI, RIOT, MNGA